Regent Pacific is a Hong Kong-based investment company holding ground-breaking corporate and strategic investments focused on the healthcare and life sciences sectors. The Group’s principal investment is Plethora Solutions Holdings plc (“Plethora”), a wholly-owned subsidiary. Plethora is a specialty pharmaceutical company that is focussed on the commercialisation of its product Fortacin™ – the first EU-approved topic...
Regent Pacific is a Hong Kong-based investment company holding ground-breaking corporate and strategic investments focused on the healthcare and life sciences sectors. The Group’s principal investment is Plethora Solutions Holdings plc (“Plethora”), a wholly-owned subsidiary. Plethora is a specialty pharmaceutical company that is focussed on the commercialisation of its product Fortacin™ – the first EU-approved topical prescription treatment for premature ejaculation – as its core product. Fortacin™ was commercially launched across key European markets (France, Germany, Italy, Spain and Portugal in early 2018
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.